Regions Financial Corporation · RF · FY2026 Q3 · Calendar Q4 2026
Regions maintains guidance as fee revenue and capital stay strong
Regions' Q3 results support a constructive operating narrative: fee businesses and commercial lending helped sustain profitability, while stable margins and CET1 above 10% provide resilience. The key test is whether deposit growth, technology execution, and credit quality can support that trajectory as rates and regulation evolve.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about RF FY2026 Q3
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with Q2, the supplied analysis shifts the emphasis toward record capital-markets and treasury-management revenue, a cloud-based deposit platform described as a major technology investment, and continued organic growth rather than immediate depository M&A. Net interest margin was 3.68%, while management maintained guidance.
Guidance delta
Guidance was maintained. Management expects full-year adjusted non-interest income growth of 3%-5% and a modest fourth-quarter lift in net interest margin from rate repricing.
Key takeaways
- Adjusted EPS was $0.73, with record capital-markets and treasury-management revenue supporting profitability.
- Net interest margin held at 3.68%; loan growth was modest and deposits declined slightly.
- Management emphasized non-interest-bearing deposits, technology modernization, and fee-based businesses as growth priorities.
Management priorities
- Pilot and fully roll out the cloud-based deposit platform throughout 2027.
- Grow non-interest-bearing deposits while maintaining a low loan-to-deposit ratio.
- Continue commercial lending, capital-markets, treasury-management, and wealth-management growth alongside share buybacks and dividends.
Follow RF with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 16, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Oct 14, 2026 |
| UBS | Neutral | Neutral | Maintain | Oct 5, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Oct 2, 2026 |
| Evercore ISI Group | Underperform | Underperform | Maintain | Oct 1, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Sep 28, 2026 |
| Truist Securities | Hold | Hold | Maintain | Sep 23, 2026 |
| Baird | Neutral | Underperform | Upgrade | Sep 18, 2026 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Jul 20, 2026 |
| DA Davidson | Neutral | Neutral | Maintain | Jul 20, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 20, 2026 |
| Wells Fargo | Underweight | Underweight | Maintain | Jul 6, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Apr 20, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Mar 30, 2026 |
| Barclays | Underweight | Underweight | Maintain | Jan 5, 2026 |
| Stephens & Co. | Equal Weight | Overweight | Downgrade | Oct 14, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 22, 2025 |
| Compass Point | Buy | Buy | Maintain | Dec 10, 2024 |
| Deutsche Bank | Buy | Hold | Upgrade | Oct 24, 2024 |
| Argus Research | Buy | Hold | Upgrade | Oct 24, 2024 |
| Wedbush | Outperform | Outperform | Maintain | Oct 21, 2024 |
| B of A Securities | Neutral | Neutral | Maintain | Jul 22, 2024 |
| Jefferies | Buy | Buy | Maintain | Jul 3, 2024 |
| Odeon Capital | Hold | Buy | Downgrade | Nov 13, 2023 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Dec 1, 2022 |
| Raymond James | Market Perform | Outperform | Downgrade | Nov 21, 2022 |
| Credit Suisse | Neutral | Neutral | Maintain | Jan 25, 2021 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Jul 20, 2020 |
| Nomura | Neutral | Neutral | Maintain | Apr 7, 2020 |
| Janney Montgomery Scott | Buy | Neutral | Upgrade | Jan 21, 2020 |
| Janney Capital | Buy | Neutral | Upgrade | Jan 21, 2020 |
| BMO Capital | Market Perform | Outperform | Downgrade | Nov 12, 2019 |
| Citi | Sell | Neutral | Downgrade | Oct 8, 2019 |
| Bank of America | Neutral | Buy | Downgrade | Jul 11, 2019 |
| Sandler O'Neill | Buy | Hold | Upgrade | Mar 25, 2019 |
| B. Riley FBR | Neutral | Neutral | Maintain | May 5, 2018 |
| B. Riley Securities | Neutral | Neutral | Maintain | Apr 24, 2018 |
| FBR Capital | Neutral | Buy | Downgrade | Oct 10, 2017 |
| Susquehanna | Neutral | Positive | Downgrade | Dec 1, 2016 |
| PiperJaffray | Neutral | Overweight | Downgrade | Nov 16, 2016 |
| Bernstein | Market Perform | Outperform | Downgrade | Aug 16, 2016 |
| Keefe Bruyette & Woods | Market Perform | Underperform | Upgrade | Jun 6, 2016 |
| Macquarie | Neutral | Outperform | Downgrade | Apr 1, 2016 |
| Sterne Agee CRT | Buy | Buy | Maintain | Oct 8, 2015 |
| Sterne Agee | Buy | Buy | Maintain | Oct 8, 2015 |
| Guggenheim | Buy | Neutral | Upgrade | Aug 28, 2015 |
| Wunderlich Securities | Hold | Buy | Downgrade | Jan 21, 2015 |
| Wunderlich | Hold | Buy | Downgrade | Jan 21, 2015 |
| Miller Tabak | Buy | Hold | Upgrade | Aug 8, 2014 |
| ISI Group | Buy | Buy | Maintain | Oct 7, 2013 |
| Sandler O'Neil | Buy | Hold | Upgrade | Mar 6, 2013 |
| Rafferty Capital | Buy | Buy | Maintain | Feb 28, 2013 |
| Drexel Hamilton | Hold | Hold | Maintain | Oct 2, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $27.43. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Cantor Fitzgerald | Analyst unavailable | $32 | $27.01 | +16.7% | Oct 14, 2026 |
| Truist Financial | Analyst unavailable | $31 | $27.6 | +13.0% | Sep 23, 2026 |
| Morgan Stanley | Analyst unavailable | $36 | $30.42 | +31.2% | Sep 8, 2026 |
| Deutsche Bank | Analyst unavailable | $34 | $30.7 | +24.0% | Aug 27, 2026 |
| Cantor Fitzgerald | Dave Rochester | $35 | $31.11 | +27.6% | Jul 21, 2026 |
| Truist Financial | Analyst unavailable | $34 | $31.11 | +24.0% | Jul 21, 2026 |
| D.A. Davidson | Analyst unavailable | $34 | $31.3 | +24.0% | Jul 20, 2026 |
| RBC Capital | Analyst unavailable | $34 | $31.65 | +24.0% | Jul 20, 2026 |
| Jefferies | David Chiaverini | $32 | $31.65 | +16.7% | Jul 17, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $34 | $30.92 | +24.0% | Jul 15, 2026 |
| Evercore ISI | Analyst unavailable | $31 | $30.36 | +13.0% | Jul 6, 2026 |
| D.A. Davidson | Analyst unavailable | $33 | $30.28 | +20.3% | Jul 6, 2026 |
| Robert W. Baird | Analyst unavailable | $28 | $30.28 | +2.1% | Jul 6, 2026 |
| Morgan Stanley | Analyst unavailable | $35 | $30.16 | +27.6% | Jun 29, 2026 |
| Truist Financial | Analyst unavailable | $30 | $28.41 | +9.4% | Apr 21, 2026 |
| RBC Capital | Analyst unavailable | $31 | $28.38 | +13.0% | Apr 20, 2026 |
| D.A. Davidson | Analyst unavailable | $32 | $28.13 | +16.7% | Apr 20, 2026 |
| UBS | Analyst unavailable | $30 | $30.48 | +9.4% | Feb 4, 2026 |
| Piper Sandler | Analyst unavailable | $31 | $27.77 | +13.0% | Jan 20, 2026 |
| Morgan Stanley | Analyst unavailable | $31 | $27.77 | +13.0% | Jan 19, 2026 |
| Wells Fargo | Analyst unavailable | $30 | $28.52 | +9.4% | Jan 16, 2026 |
| Goldman Sachs | Analyst unavailable | $32 | $28.18 | +16.7% | Jan 6, 2026 |
| Barclays | Analyst unavailable | $30 | $27.56 | +9.4% | Jan 5, 2026 |
| Truist Financial | Analyst unavailable | $29 | $27.78 | +5.7% | Dec 22, 2025 |
| Stephens | Analyst unavailable | $27 | $24.56 | -1.6% | Oct 14, 2025 |
| Evercore ISI | John Pancari | $29 | $26.5 | +5.7% | Sep 30, 2025 |
| Morgan Stanley | Analyst unavailable | $32 | $26.63 | +16.7% | Sep 29, 2025 |
| Cantor Fitzgerald | Dave Rochester | $30 | $26.82 | +9.4% | Sep 9, 2025 |
| Barclays | Jason Goldberg | $27 | $26.24 | -1.6% | Jul 21, 2025 |
| Stephens | Terry McEvoy | $26 | $24.08 | -5.2% | Oct 29, 2024 |
| Argus Research | Kevin Heal | $26 | $23.78 | -5.2% | Oct 24, 2024 |
| Deutsche Bank | Matt O'Connor | $26 | $23.64 | -5.2% | Oct 24, 2024 |
| Truist Financial | Brandon King | $26 | $23.82 | -5.2% | Oct 21, 2024 |
| D.A. Davidson | Peter Winter | $29 | $23.82 | +5.7% | Oct 21, 2024 |
| Evercore ISI | John Pancari | $26 | $22.54 | -5.2% | Oct 2, 2024 |
| Wedbush | David Chiaverini | $28 | $22.91 | +2.1% | Sep 24, 2024 |
| Citigroup | Keith Horowitz | $26 | $22.72 | -5.2% | Sep 19, 2024 |
| Piper Sandler | Scott Siefers | $23 | $23.07 | -16.2% | Sep 3, 2024 |
| Morgan Stanley | Betsy Graseck | $28 | $22.43 | +2.1% | Jul 30, 2024 |
| D.A. Davidson | Peter Winter | $26 | $22.39 | -5.2% | Jul 22, 2024 |
| Truist Financial | Brandon King | $23 | $22.39 | -16.2% | Jul 22, 2024 |
| Robert W. Baird | David George | $21 | $22.09 | -23.4% | Jul 22, 2024 |
| RBC Capital | Gerard Cassidy | $23 | $22.09 | -16.2% | Jul 22, 2024 |
| Wells Fargo | Mike Mayo | $22 | $22.09 | -19.8% | Jul 21, 2024 |
| Jefferies | Ken Usdin | $24 | $20.09 | -12.5% | Jul 3, 2024 |
| UBS | Erika Najarian | $22 | $20.51 | -19.8% | Apr 4, 2024 |
| Piper Sandler | Scott Siefers | $15 | $14.1 | -45.3% | Oct 25, 2023 |
| Barclays | Analyst unavailable | $29 | $21.92 | +5.7% | Jan 3, 2023 |
| D.A. Davidson | Analyst unavailable | $25 | $20.71 | -8.9% | Dec 21, 2022 |
| Morgan Stanley | Analyst unavailable | $28 | $20.4 | +2.1% | Dec 16, 2022 |
| Jefferies | Ken Usdin | $22 | $18.92 | -19.8% | Jul 11, 2022 |
| UBS | Erika Najarian | $32 | $24.59 | +16.7% | Jan 12, 2022 |
| Evercore ISI | John Pancari | $27 | $23.88 | -1.6% | Nov 16, 2021 |
| Odeon Capital Group LLC | Richard Bove | $27.7 | $23.8 | +1.0% | Nov 10, 2021 |
| Piper Sandler | Stephen Scouten | $28 | $23.85 | +2.1% | Oct 25, 2021 |
| Wells Fargo | Mike Mayo | $24 | $21.49 | -12.5% | Oct 4, 2021 |
| KBW | David Konrad | $18 | $19.12 | -34.4% | Jul 6, 2021 |
| Compass Point | Dave Rochester | $25 | $22.19 | -8.9% | May 18, 2021 |
Track every rating change on RF the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationRegions Financial Corporation (RF) operates as a financial holding company, delivering a comprehensive array of banking and related services to both individual consumers and corporate entities. The firm's operations are strategically divided into three principal divisions: Corporate Bank, Consumer Bank, and Wealth Management. The Corporate Bank segment specializes in commercial banking solutions. Its extensive offerings include various lending options such as commercial and industrial loans, commercial real estate financing, and investor real estate credit. Furthermore, it provides equipment lease financing, manages diverse deposit products, and offers sophisticated capital markets services like securities underwriting and placement, loan syndication, foreign exchange, derivatives, and merger and acquisition advisory, along with other consulting services. This segment primarily serves corporate clients, middle-market businesses, and developers and investors in commercial real estate.…
Historical context
All RF earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| MTB-PJ M&T Bank Corporation | FY2026 Q3 · Calendar Q4 2026 | — | — | M&T Bank highlights deposits, CRE growth and AI efficiency in Q3 |
| RF-PE Regions Financial Corporation | FY2026 Q3 · Calendar Q4 2026 | — | — | Regions Financial: Fee Growth and Technology Investment Lead Q3 Readout |
| MTB-PH M&T Bank Corporation | FY2026 Q3 · Calendar Q4 2026 | — | — | M&T: Loan and Deposit Growth Offset a Modest Q3 Earnings Decline |
| RF-PC Regions Financial Corporation | FY2026 Q3 · Calendar Q4 2026 | — | — | Regions Financial Maintains Growth Outlook as Fee Revenue Sets Records |
| TFC-PI Truist Financial Corporation | FY2026 Q3 · Calendar Q4 2026 | — | — | Truist refocuses on relationship banking while investing for growth |
| TRV The Travelers Companies, Inc. | FY2026 Q3 · Calendar Q4 2026 | — | +0.5% | Travelers posts strong Q3 underwriting results as AI investment continues |
Latest beats and misses
Who reports nextBeat on EPS
- AAFY2026 Q3 · October 15, 2026+20.5% EPS+7.2% move
- JBHTFY2026 Q3 · October 15, 2026+0.6% EPS-2.0% move
- PLDFY2026 Q3 · October 15, 2026+105.9% EPS-2.7% move
- BNYFY2026 Q3 · October 15, 2026+4.4% EPS+3.2% move
- USB-PRFY2026 Q3 · October 15, 2026+1.5% EPS— move
- USB-PSFY2026 Q3 · October 15, 2026+1.5% EPS— move
Get the RF recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-10-16T16:03:17.387516+00:00
- FN2 earnings calendar · 2026-10-16T01:23:22.079841+00:00
- Polygon adjusted daily market bars · 2026-10-16T17:30:43.880835+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-16T17:30:43.878048+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-16. For educational purposes only; not investment advice.